A Case Report of Pulmonary‐Renal Syndrome Treated With Continuous Hemodiafiltration and Hemodialysis

:  This case describes a 40‐year‐old man complaining of general malaise, dyspnea with hemoptysis and anuria. Laboratory data indicated renal failure and the presence of systemic inflammation. His chest radiograph and computed tomography showed bilateral diffuse interstitial alveolar infiltration. Th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Therapeutic apheresis and dialysis 2006-10, Vol.10 (5), p.467-471
Hauptverfasser: Uji, Yoshitaka, Shimizu, Tomoharu, Yoshioka, Toyokazu, Yamamoto, Hiroshi, Endo, Yoshihiro, Tani, Toru
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 471
container_issue 5
container_start_page 467
container_title Therapeutic apheresis and dialysis
container_volume 10
creator Uji, Yoshitaka
Shimizu, Tomoharu
Yoshioka, Toyokazu
Yamamoto, Hiroshi
Endo, Yoshihiro
Tani, Toru
description :  This case describes a 40‐year‐old man complaining of general malaise, dyspnea with hemoptysis and anuria. Laboratory data indicated renal failure and the presence of systemic inflammation. His chest radiograph and computed tomography showed bilateral diffuse interstitial alveolar infiltration. These findings indicated acute deterioration of chronic renal dysfunction complicated by interstitial pneumonitis. He initially received daily conventional hemodialysis (HD), an antibiotic and oxygen therapy. However, his renal and pulmonary function continued to deteriorate. Antineutrophil cytoplasm antibodies against myeloperoxidase (MPO‐ANCA) and antibodies against proteinase 3 (PR3‐ANCA) were negative. We suspected that his pulmonary‐renal syndrome was caused by ANCA‐negative vasculitis. We applied mechanical ventilation, pulsed methylprednisolone therapy and continuous hemodiafiltration (CHDF) combined with HD. PaO2/FiO2 ratio and mean pulmonary arterial pressure gradually improved after initiation of CHDF. He was finally separated from mechanical ventilation after 44 days in the hospital. He is currently alive with the support of conventional HD.
doi_str_mv 10.1111/j.1744-9987.2006.00411.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68140894</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68140894</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3901-d0a95c1731112cc4358016079786d46b83be88b9a5e26bdc1c571083d5bb2cfa3</originalsourceid><addsrcrecordid>eNqNkEtOwzAQhi0EoqVwBeQVuwY7TmJbYlNVQJEqUZUilpZjO8JVEhc7Ee2OI3BGTkJKS9kymxnN_PP6AIAYRbiz62WEaZIMOWc0ihHKIoQSjKP1EegfCseHmPIeOAthiVAcJ4Scgh6miGcUkT4oRnAsg4Fzs3K-ga6As7asXC395uvjc25qWcKnTa29qwxceCMbo-GLbV7h2NWNrVvXBjgxldNWFrZsvGysq6Gs9W-23AQbzsFJIctgLvZ-AJ7vbhfjyXD6eP8wHk2HinCEhxpJnipMSfdkrFRCUoZwhiinLNNJljOSG8ZyLlMTZ7lWWKUUI0Z0muexKiQZgKvd3JV3b60JjahsUKYsZW26S0XGcIIYTzoh2wmVdyF4U4iVt1X3tcBIbBmLpdjiE1uUYstY_DAW6671cr-jzSuj_xr3UDvBzU7wbkuz-fdgsRjNuoB8A9SIi_w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68140894</pqid></control><display><type>article</type><title>A Case Report of Pulmonary‐Renal Syndrome Treated With Continuous Hemodiafiltration and Hemodialysis</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Uji, Yoshitaka ; Shimizu, Tomoharu ; Yoshioka, Toyokazu ; Yamamoto, Hiroshi ; Endo, Yoshihiro ; Tani, Toru</creator><creatorcontrib>Uji, Yoshitaka ; Shimizu, Tomoharu ; Yoshioka, Toyokazu ; Yamamoto, Hiroshi ; Endo, Yoshihiro ; Tani, Toru</creatorcontrib><description>:  This case describes a 40‐year‐old man complaining of general malaise, dyspnea with hemoptysis and anuria. Laboratory data indicated renal failure and the presence of systemic inflammation. His chest radiograph and computed tomography showed bilateral diffuse interstitial alveolar infiltration. These findings indicated acute deterioration of chronic renal dysfunction complicated by interstitial pneumonitis. He initially received daily conventional hemodialysis (HD), an antibiotic and oxygen therapy. However, his renal and pulmonary function continued to deteriorate. Antineutrophil cytoplasm antibodies against myeloperoxidase (MPO‐ANCA) and antibodies against proteinase 3 (PR3‐ANCA) were negative. We suspected that his pulmonary‐renal syndrome was caused by ANCA‐negative vasculitis. We applied mechanical ventilation, pulsed methylprednisolone therapy and continuous hemodiafiltration (CHDF) combined with HD. PaO2/FiO2 ratio and mean pulmonary arterial pressure gradually improved after initiation of CHDF. He was finally separated from mechanical ventilation after 44 days in the hospital. He is currently alive with the support of conventional HD.</description><identifier>ISSN: 1744-9979</identifier><identifier>EISSN: 1744-9987</identifier><identifier>DOI: 10.1111/j.1744-9987.2006.00411.x</identifier><identifier>PMID: 17096703</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Adult ; ANCA ; C-Reactive Protein - analysis ; Combined Modality Therapy ; Continuous hemodiafiltration ; Glucocorticoids - administration &amp; dosage ; Hemodiafiltration ; Hemodialysis ; Humans ; Kidney Failure, Chronic - complications ; Kidney Failure, Chronic - therapy ; Leukocytes ; Lung Diseases, Interstitial - complications ; Male ; Methylprednisolone - administration &amp; dosage ; Potassium - analysis ; Pulmonary‐renal syndrome ; Pulse Therapy, Drug ; Renal Dialysis ; Syndrome ; Tomography, X-Ray Computed ; Vasculitis - complications</subject><ispartof>Therapeutic apheresis and dialysis, 2006-10, Vol.10 (5), p.467-471</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3901-d0a95c1731112cc4358016079786d46b83be88b9a5e26bdc1c571083d5bb2cfa3</citedby><cites>FETCH-LOGICAL-c3901-d0a95c1731112cc4358016079786d46b83be88b9a5e26bdc1c571083d5bb2cfa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1744-9987.2006.00411.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1744-9987.2006.00411.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,45579,45580</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17096703$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uji, Yoshitaka</creatorcontrib><creatorcontrib>Shimizu, Tomoharu</creatorcontrib><creatorcontrib>Yoshioka, Toyokazu</creatorcontrib><creatorcontrib>Yamamoto, Hiroshi</creatorcontrib><creatorcontrib>Endo, Yoshihiro</creatorcontrib><creatorcontrib>Tani, Toru</creatorcontrib><title>A Case Report of Pulmonary‐Renal Syndrome Treated With Continuous Hemodiafiltration and Hemodialysis</title><title>Therapeutic apheresis and dialysis</title><addtitle>Ther Apher Dial</addtitle><description>:  This case describes a 40‐year‐old man complaining of general malaise, dyspnea with hemoptysis and anuria. Laboratory data indicated renal failure and the presence of systemic inflammation. His chest radiograph and computed tomography showed bilateral diffuse interstitial alveolar infiltration. These findings indicated acute deterioration of chronic renal dysfunction complicated by interstitial pneumonitis. He initially received daily conventional hemodialysis (HD), an antibiotic and oxygen therapy. However, his renal and pulmonary function continued to deteriorate. Antineutrophil cytoplasm antibodies against myeloperoxidase (MPO‐ANCA) and antibodies against proteinase 3 (PR3‐ANCA) were negative. We suspected that his pulmonary‐renal syndrome was caused by ANCA‐negative vasculitis. We applied mechanical ventilation, pulsed methylprednisolone therapy and continuous hemodiafiltration (CHDF) combined with HD. PaO2/FiO2 ratio and mean pulmonary arterial pressure gradually improved after initiation of CHDF. He was finally separated from mechanical ventilation after 44 days in the hospital. He is currently alive with the support of conventional HD.</description><subject>Adult</subject><subject>ANCA</subject><subject>C-Reactive Protein - analysis</subject><subject>Combined Modality Therapy</subject><subject>Continuous hemodiafiltration</subject><subject>Glucocorticoids - administration &amp; dosage</subject><subject>Hemodiafiltration</subject><subject>Hemodialysis</subject><subject>Humans</subject><subject>Kidney Failure, Chronic - complications</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Leukocytes</subject><subject>Lung Diseases, Interstitial - complications</subject><subject>Male</subject><subject>Methylprednisolone - administration &amp; dosage</subject><subject>Potassium - analysis</subject><subject>Pulmonary‐renal syndrome</subject><subject>Pulse Therapy, Drug</subject><subject>Renal Dialysis</subject><subject>Syndrome</subject><subject>Tomography, X-Ray Computed</subject><subject>Vasculitis - complications</subject><issn>1744-9979</issn><issn>1744-9987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEtOwzAQhi0EoqVwBeQVuwY7TmJbYlNVQJEqUZUilpZjO8JVEhc7Ee2OI3BGTkJKS9kymxnN_PP6AIAYRbiz62WEaZIMOWc0ihHKIoQSjKP1EegfCseHmPIeOAthiVAcJ4Scgh6miGcUkT4oRnAsg4Fzs3K-ga6As7asXC395uvjc25qWcKnTa29qwxceCMbo-GLbV7h2NWNrVvXBjgxldNWFrZsvGysq6Gs9W-23AQbzsFJIctgLvZ-AJ7vbhfjyXD6eP8wHk2HinCEhxpJnipMSfdkrFRCUoZwhiinLNNJljOSG8ZyLlMTZ7lWWKUUI0Z0muexKiQZgKvd3JV3b60JjahsUKYsZW26S0XGcIIYTzoh2wmVdyF4U4iVt1X3tcBIbBmLpdjiE1uUYstY_DAW6671cr-jzSuj_xr3UDvBzU7wbkuz-fdgsRjNuoB8A9SIi_w</recordid><startdate>200610</startdate><enddate>200610</enddate><creator>Uji, Yoshitaka</creator><creator>Shimizu, Tomoharu</creator><creator>Yoshioka, Toyokazu</creator><creator>Yamamoto, Hiroshi</creator><creator>Endo, Yoshihiro</creator><creator>Tani, Toru</creator><general>Blackwell Publishing Asia</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200610</creationdate><title>A Case Report of Pulmonary‐Renal Syndrome Treated With Continuous Hemodiafiltration and Hemodialysis</title><author>Uji, Yoshitaka ; Shimizu, Tomoharu ; Yoshioka, Toyokazu ; Yamamoto, Hiroshi ; Endo, Yoshihiro ; Tani, Toru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3901-d0a95c1731112cc4358016079786d46b83be88b9a5e26bdc1c571083d5bb2cfa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>ANCA</topic><topic>C-Reactive Protein - analysis</topic><topic>Combined Modality Therapy</topic><topic>Continuous hemodiafiltration</topic><topic>Glucocorticoids - administration &amp; dosage</topic><topic>Hemodiafiltration</topic><topic>Hemodialysis</topic><topic>Humans</topic><topic>Kidney Failure, Chronic - complications</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Leukocytes</topic><topic>Lung Diseases, Interstitial - complications</topic><topic>Male</topic><topic>Methylprednisolone - administration &amp; dosage</topic><topic>Potassium - analysis</topic><topic>Pulmonary‐renal syndrome</topic><topic>Pulse Therapy, Drug</topic><topic>Renal Dialysis</topic><topic>Syndrome</topic><topic>Tomography, X-Ray Computed</topic><topic>Vasculitis - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uji, Yoshitaka</creatorcontrib><creatorcontrib>Shimizu, Tomoharu</creatorcontrib><creatorcontrib>Yoshioka, Toyokazu</creatorcontrib><creatorcontrib>Yamamoto, Hiroshi</creatorcontrib><creatorcontrib>Endo, Yoshihiro</creatorcontrib><creatorcontrib>Tani, Toru</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Therapeutic apheresis and dialysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uji, Yoshitaka</au><au>Shimizu, Tomoharu</au><au>Yoshioka, Toyokazu</au><au>Yamamoto, Hiroshi</au><au>Endo, Yoshihiro</au><au>Tani, Toru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Case Report of Pulmonary‐Renal Syndrome Treated With Continuous Hemodiafiltration and Hemodialysis</atitle><jtitle>Therapeutic apheresis and dialysis</jtitle><addtitle>Ther Apher Dial</addtitle><date>2006-10</date><risdate>2006</risdate><volume>10</volume><issue>5</issue><spage>467</spage><epage>471</epage><pages>467-471</pages><issn>1744-9979</issn><eissn>1744-9987</eissn><abstract>:  This case describes a 40‐year‐old man complaining of general malaise, dyspnea with hemoptysis and anuria. Laboratory data indicated renal failure and the presence of systemic inflammation. His chest radiograph and computed tomography showed bilateral diffuse interstitial alveolar infiltration. These findings indicated acute deterioration of chronic renal dysfunction complicated by interstitial pneumonitis. He initially received daily conventional hemodialysis (HD), an antibiotic and oxygen therapy. However, his renal and pulmonary function continued to deteriorate. Antineutrophil cytoplasm antibodies against myeloperoxidase (MPO‐ANCA) and antibodies against proteinase 3 (PR3‐ANCA) were negative. We suspected that his pulmonary‐renal syndrome was caused by ANCA‐negative vasculitis. We applied mechanical ventilation, pulsed methylprednisolone therapy and continuous hemodiafiltration (CHDF) combined with HD. PaO2/FiO2 ratio and mean pulmonary arterial pressure gradually improved after initiation of CHDF. He was finally separated from mechanical ventilation after 44 days in the hospital. He is currently alive with the support of conventional HD.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>17096703</pmid><doi>10.1111/j.1744-9987.2006.00411.x</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1744-9979
ispartof Therapeutic apheresis and dialysis, 2006-10, Vol.10 (5), p.467-471
issn 1744-9979
1744-9987
language eng
recordid cdi_proquest_miscellaneous_68140894
source MEDLINE; Access via Wiley Online Library
subjects Adult
ANCA
C-Reactive Protein - analysis
Combined Modality Therapy
Continuous hemodiafiltration
Glucocorticoids - administration & dosage
Hemodiafiltration
Hemodialysis
Humans
Kidney Failure, Chronic - complications
Kidney Failure, Chronic - therapy
Leukocytes
Lung Diseases, Interstitial - complications
Male
Methylprednisolone - administration & dosage
Potassium - analysis
Pulmonary‐renal syndrome
Pulse Therapy, Drug
Renal Dialysis
Syndrome
Tomography, X-Ray Computed
Vasculitis - complications
title A Case Report of Pulmonary‐Renal Syndrome Treated With Continuous Hemodiafiltration and Hemodialysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T03%3A33%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Case%20Report%20of%20Pulmonary%E2%80%90Renal%20Syndrome%20Treated%20With%20Continuous%20Hemodiafiltration%20and%20Hemodialysis&rft.jtitle=Therapeutic%20apheresis%20and%20dialysis&rft.au=Uji,%20Yoshitaka&rft.date=2006-10&rft.volume=10&rft.issue=5&rft.spage=467&rft.epage=471&rft.pages=467-471&rft.issn=1744-9979&rft.eissn=1744-9987&rft_id=info:doi/10.1111/j.1744-9987.2006.00411.x&rft_dat=%3Cproquest_cross%3E68140894%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68140894&rft_id=info:pmid/17096703&rfr_iscdi=true